KBR Stock Analysis: KBR | NYSE
Engineering & Construction | NYSE, USA | Market Cap: 4.687m USD | 12M Return: -15.5% | US48242W1062 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 70.1M
EPS Trend: 97.7%
Qual. Beats: 5
Rev. Trend: 74.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.9 years of data, until 10/2026
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.
KBR, Inc. (NYSE: KBR) is a Houston-based provider of scientific, technology, and engineering solutions serving both government and commercial clients worldwide. Founded in 1901 and publicly listed since its 2006 IPO, the company operates as a mid-cap industrial firm within the GICS Research & Consulting Services sub-industry.
The business is organized into two main segments. The Government Solutions segment delivers research and development, advanced prototyping, systems engineering, cyber analytics, space domain awareness, test and evaluation, and program management support to defense, intelligence, space, and aviation agencies, including C5ISR (command, control, communications, computers, intelligence, surveillance, and reconnaissance) services. The Sustainable Technology Solutions segment licenses a portfolio of proprietary process technologies in ammonia/syngas, petrochemicals, clean refining, and circular economy applications, while also offering engineering, design, and digitally-enabled services focused on decarbonization, energy efficiency, and net-zero carbon emissions.
This dual structure positions KBR at the intersection of government defense contracting and the global energy transition, with its proprietary process technology licensing serving as a distinct revenue stream alongside traditional services work.
- U.S. defense budget growth fuels Government Solutions segment backlog
- Sustainable Technology Solutions margins expand on energy transition contracts
- Federal R&D funding surge boosts KBR science and engineering backlog
| Net Income: 442.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -2.54 > 1.0 |
| NWC/Revenue: -1.89% < 20% (prev 3.90%; Δ -5.79% < -1%) |
| CFO/TA 0.05 > 3% & CFO 377.0m > Net Income 442.0m |
| Net Debt (2.57b) to EBITDA (907.0m): 2.84 < 3 |
| Current Ratio: 0.94 > 1.5 & < 3 |
| Outstanding Shares: last quarter (126.0m) vs 12m ago -1.56% < -2% |
| Gross Margin: 14.69% > 18% (prev 14.28%; Δ 0.41% > 0.5%) |
| Asset Turnover: 114.4% > 50% (prev 121.2%; Δ -6.79% > 0%) |
| Interest Coverage Ratio: 4.75 > 6 (EBIT TTM 741.0m / Interest Expense TTM 156.0m) |
| A: -0.02 (Total Current Assets 2.30b - Total Current Liabilities 2.45b) / Total Assets 7.02b |
| B: 0.28 (Retained Earnings 1.97b / Total Assets 7.02b) |
| C: 0.11 (EBIT TTM 741.0m / Avg Total Assets 6.83b) |
| D: 0.34 (Book Value of Equity 1.76b / Total Liabilities 5.24b) |
| Altman-Z'' = 1.86 = BBB |
| DSRI: 0.98 (Receivables 1.30b/1.37b, Revenue 7.82b/8.06b) |
| GMI: 0.97 (GM 14.28% / 14.69%) |
| AQI: 0.98 (AQ_t 0.61 / AQ_t-1 0.62) |
| SGI: 0.97 (Revenue 7.82b / 8.06b) |
| TATA: 0.01 (NI 442.0m - CFO 377.0m) / TA 7.02b) |
| Beneish M = -3.10 (Cap -4..+1) = AA |
As of November 13, 2026, the stock is trading at USD 35.32 with a total of 2,452,921 shares traded. Over the past week, the price has changed by -7.15%, over one month by +0.37%, over three months by -6.88% and over the past year by -15.49%.
Current recommended Stop Loss: 32.70 (which is 7.4% or 1.7 ATR below the current price).
KBR has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy KBR.
- StrongBuy: 4
- Buy: 0
- Hold: 4
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 44.1 | 25% |
P/E Trailing = 10.8052
P/E Forward = 8.8261
P/S = 0.5994
P/B = 2.6573
P/EG = 0.541
Revenue TTM = 7.82b USD
EBIT TTM = 741.0m USD
EBITDA TTM = 907.0m USD
Long Term Debt = 1.99b USD (from longTermDebt, last quarter)
Short Term Debt = 554.0m USD (from shortTermDebt, last quarter)
Debt = 3.01b USD (from shortLongTermDebtTotal, last quarter) + Leases 236.0m
Net Debt = 2.57b USD (calculated: Debt 3.01b - CCE 439.0m)
Enterprise Value = 7.26b USD (4.69b + Debt 3.01b - CCE 439.0m)
Interest Coverage Ratio = 4.75 (Ebit TTM 741.0m / Interest Expense TTM 156.0m)
EV/FCF = 22.48x (Enterprise Value 7.26b / FCF TTM 323.0m)
FCF Yield = 4.45% (FCF TTM 323.0m / Enterprise Value 7.26b)
FCF Margin = 4.13% (FCF TTM 323.0m / Revenue TTM 7.82b)
Net Margin = 5.65% (Net Income TTM 442.0m / Revenue TTM 7.82b)
Gross Margin = 14.69% ((Revenue TTM 7.82b - Cost of Revenue TTM 6.67b) / Revenue TTM)
Gross Margin QoQ = 14.84% (prev 14.77%)
Tobins Q-Ratio = 1.03 (Enterprise Value 7.26b / Total Assets 7.02b)
Interest Expense / Debt = 5.18% (Interest Expense 156.0m / Debt 3.01b)
Taxrate = 23.41% (136.0m / 581.0m)
NOPAT = 567.5m (EBIT 741.0m * (1 - 23.41%))
Current Ratio = 0.94 (Total Current Assets 2.30b / Total Current Liabilities 2.45b)
Debt / Equity = 1.71 (Debt 3.01b / totalStockholderEquity, last quarter 1.76b)
Debt / EBITDA = 2.84 (Net Debt 2.57b / EBITDA 907.0m)
Debt / FCF = 7.97 (Net Debt 2.57b / FCF TTM 323.0m)
Total Stockholder Equity = 1.62b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.47% (Net Income 442.0m / Total Assets 7.02b)
RoE = 27.25% (Net Income TTM 442.0m / Total Stockholder Equity 1.62b)
RoCE = 20.53% (EBIT 741.0m / Capital Employed (Equity 1.62b + L.T.Debt 1.99b))
RoIC = 11.99% (NOPAT 567.5m / Invested Capital 4.74b)
WACC = 5.65% (E(4.69b)/V(7.70b) * Re(6.74%) + D(3.01b)/V(7.70b) * Rd(5.18%) * (1-Tc(0.23)))
Discount Rate = 6.74% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -96.26 | Cagr: -2.70%
[DCF] Terminal Value 73.10% ; FCFF base≈383.8m ; Y1≈336.6m ; Y5≈271.9m
[DCF] Fair Price = 14.20 (EV 4.36b - Net Debt 2.57b = Equity 1.79b / Shares 126.1m; r=8.35% [WACC [floored]]; 5y FCF grow -15.0% → 2.50% )
EPS Correlation: 97.72 | EPS CAGR: 14.64% | SUE: 2.90 | # QB: 5
Revenue Correlation: 74.37 | Revenue CAGR: 4.35% | SUE: -0.17 | # QB: 0
EPS current Quarter (2027-03-31): EPS=0.99 | Chg30d=-5.80% | Revisions=-25% | Analysts=4
EPS current Year (2026-12-31): EPS=4.06 | Chg30d=+1.57% | Revisions=+29% | GrowthEPS=+3.2% | GrowthRev=+3.0%
EPS next Year (2027-12-31): EPS=4.02 | Chg30d=-1.05% | Revisions=+0% | GrowthEPS=-0.9% | GrowthRev=+5.3%
[Analyst] Revisions Ratio: +8% (up=5, down=4)